ATE151295T1 - Zweikomponenten-fibrinkleber zur verbesserung von in-vitro befruchtung - Google Patents

Zweikomponenten-fibrinkleber zur verbesserung von in-vitro befruchtung

Info

Publication number
ATE151295T1
ATE151295T1 AT93915861T AT93915861T ATE151295T1 AT E151295 T1 ATE151295 T1 AT E151295T1 AT 93915861 T AT93915861 T AT 93915861T AT 93915861 T AT93915861 T AT 93915861T AT E151295 T1 ATE151295 T1 AT E151295T1
Authority
AT
Austria
Prior art keywords
component
improve
vitro fertilization
fibrin adhesive
component fibrin
Prior art date
Application number
AT93915861T
Other languages
English (en)
Inventor
Efrach Barnea
Original Assignee
Omrix Biopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omrix Biopharm Sa filed Critical Omrix Biopharm Sa
Application granted granted Critical
Publication of ATE151295T1 publication Critical patent/ATE151295T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93915861T 1992-07-18 1993-07-09 Zweikomponenten-fibrinkleber zur verbesserung von in-vitro befruchtung ATE151295T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92112295 1992-07-18
EP93105298 1993-03-30

Publications (1)

Publication Number Publication Date
ATE151295T1 true ATE151295T1 (de) 1997-04-15

Family

ID=26131003

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93915861T ATE151295T1 (de) 1992-07-18 1993-07-09 Zweikomponenten-fibrinkleber zur verbesserung von in-vitro befruchtung

Country Status (12)

Country Link
JP (1) JPH08502035A (de)
KR (1) KR950702434A (de)
AT (1) ATE151295T1 (de)
AU (1) AU4566893A (de)
CA (1) CA2140427A1 (de)
CZ (1) CZ5495A3 (de)
DE (1) DE69309685T2 (de)
FI (1) FI950194A (de)
HU (1) HUT71873A (de)
IL (1) IL106293A0 (de)
SK (1) SK5095A3 (de)
WO (1) WO1994002182A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691858B1 (de) * 1993-03-30 1999-12-15 Omrix Biopharmaceuticals S.A. Zweikomponenten-fibrinkleber
US5411885A (en) * 1993-12-17 1995-05-02 New York Blood Center, Inc. Methods for tissue embedding and tissue culturing
WO1996003160A1 (en) * 1994-07-26 1996-02-08 Children's Medical Center Corporation Fibrin-cell suspension for construction of new tissue
CA2207992A1 (en) * 1995-01-16 1996-07-25 Genevieve Krack Self-supporting sheet-like material of cross-linked fibrin for preventing post operative adhesions
CA2308462C (en) * 1997-11-17 2009-02-24 Haemacure Corporation Fibrin sealants or adhesives comprising a hyaluronic acid derivative material

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT369990B (de) * 1981-07-28 1983-02-25 Immuno Ag Verfahren zur herstellung eines gewebeklebstoffes
US4904259A (en) * 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
CH681693A5 (de) * 1991-02-28 1993-05-14 Pentapharm Ag
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive

Also Published As

Publication number Publication date
FI950194A0 (fi) 1995-01-17
WO1994002182A1 (en) 1994-02-03
IL106293A0 (en) 1993-11-15
DE69309685D1 (de) 1997-05-15
CA2140427A1 (en) 1994-02-03
HUT71873A (en) 1996-02-28
SK5095A3 (en) 1995-07-11
JPH08502035A (ja) 1996-03-05
KR950702434A (ko) 1995-07-29
DE69309685T2 (de) 1997-10-16
HU9500141D0 (en) 1995-03-28
AU4566893A (en) 1994-02-14
CZ5495A3 (en) 1995-06-14
FI950194A (fi) 1995-01-17

Similar Documents

Publication Publication Date Title
DE69229272T2 (de) Topischer fibrinogenkomplex
ATE187651T1 (de) Zweikomponenten-fibrinkleber
ES2196436T3 (es) Acidos sulfonilalcanoilamino-hidroxietilamino-sulfamicos utiles como inhibidores de proteasas retrovirales.
NO923737L (no) Forbedret vevs-lim fremstilt ved anvendelse av kryopresipitat
ATE151295T1 (de) Zweikomponenten-fibrinkleber zur verbesserung von in-vitro befruchtung
ES2091280T3 (es) Composicion detergente liquida que contiene lipasa y proteasa.
AU670571B2 (en) A method of proteolytically cleaving proteins and the use of said method
DK0570354T3 (da) Fremgangsmåde til bestemmelse af fibrinogen
AU6348686A (en) A protein reagent having the ability to bind tissue plasminogen activator in its two chain form and/or its single chain form
NO950171L (no) To-komponent fibrin-limblanding for å forbedre in vitro fruktbarhet
EP0292326A3 (de) Modifiziertes Enzym